Core Viewpoint - The company is expected to show strong growth in Q3 2025, with significant increases in revenue and adjusted net profit driven by new product launches and continuous channel growth [1][2] Financial Performance - For Q3 2025, the company anticipates a revenue growth of 154.2% year-on-year, reaching approximately 9.17 billion yuan, and an adjusted net profit growth of 198.6%, amounting to about 3.03 billion yuan [1] - The adjusted profit margin is projected to be 33% [1] Product Development - In Q3 2025, the company plans to launch 31 new series of blind box figures and plush products, with a slight decrease in new series compared to the previous quarter but maintaining year-on-year levels [1] - Popular new products include various themed series that sold out on their launch day [1] Retail Expansion - As of the end of August, the company had 513 retail stores in mainland China, a 6.4% increase year-on-year, and 1,837 robot stores [1] - The average revenue per store increased by 57% to 2.48 million yuan for the July-August period [1] Online Sales Performance - The company's official Douyin flagship store achieved a GMV of 1.31 billion yuan in Q3 2025, a year-on-year increase of 302.2%, with sales volume reaching 9.49 million, up 677.9% [2] - The Tmall flagship store generated revenue of 251 million yuan, a 73.1% increase year-on-year, while JD.com saw a revenue increase of 99.6% for the same period [2] Future Outlook - The company has adjusted its profit forecasts for 2025-2027, with expected adjusted net profits of 10.96 billion, 14.92 billion, and 18.31 billion yuan respectively [2] - The adjusted PE ratios for 2025-2027 are projected to be 32.3x, 23.8x, and 19.4x [2]

Core Viewpoint - The article highlights the resurgence of the Hong Kong IPO market driven by sectors such as artificial intelligence, new consumption, and innovative pharmaceuticals, with expectations for continued activity in 2025 [1][3]. Group 1: IPO Market Dynamics - The Hong Kong IPO market is projected to remain active in 2025, with an estimated 90 to 100 companies expected to list, raising over 200 billion HKD [1]. - As of mid-July, approximately 288 companies are in the IPO queue, indicating a strong pipeline of upcoming listings [5]. - The recent IPO of CATL in Hong Kong marked a significant milestone, raising approximately 30.72 billion HKD, making it the largest IPO globally this year [3]. Group 2: Foreign Investment Sentiment - There is a notable recovery in foreign investor interest in Hong Kong IPOs, with overseas long-term funds increasingly participating in the market [2][5]. - Foreign investors contributed 42% of the IPO financing this year, with two-thirds of this coming from overseas investors [5]. Group 3: Sector Focus - Key sectors attracting investor attention include AI-related hardware and software, biopharmaceuticals, new consumption, and high-end manufacturing [7][10]. - The innovative pharmaceutical sector has seen significant foreign interest, with over 1 billion USD in overseas licensing orders becoming commonplace [8]. - The Hang Seng Biotechnology Index has surged by 90.66% this year, significantly outperforming the Nasdaq Biotechnology Index [8]. Group 4: Future Trends - The article anticipates continued interest in biopharmaceutical IPOs, particularly in oncology and autoimmune disease areas, with a growing trend of Chinese companies retaining some overseas participation rights [9]. - New consumption brands, including those in the food and beverage sector, are also gaining traction, with several companies preparing for IPOs in Hong Kong [10].

Core Viewpoint - The company reported a significant year-on-year revenue growth of 245%-250% for Q3 2025, exceeding market expectations, with strong performance across various channels and regions [1][2]. Revenue Performance - Domestic revenue in China grew by 185%-190%, with offline channels increasing by 130%-135% and online channels by 300%-305% [1]. - Overseas revenue surged by 365%-370%, with specific growth rates of 170%-175% in the Asia-Pacific region, 1265%-1270% in the Americas, and 735%-740% in Europe and other regions [1]. IP Development and Longevity - The commercial value curve of the labubu IP does not align with its popularity curve, indicating that high-quality IPs have a longer lifecycle than market perceptions suggest [1]. - Historical data shows that most of the company's key IPs have achieved continuous year-on-year revenue growth, with MOLLY, an early artist IP, maintaining a CAGR of 22% from 2019 to 2023 [1]. Global Market Expansion - The company is leveraging its diverse IP matrix to enhance its presence in global markets, which is crucial for catering to varying cultural preferences [2]. - The success of multiple IPs in overseas markets, such as crybaby and 星星人, demonstrates a notable increase in popularity, with regional differences in demand [2]. - The company is optimistic about expanding its store presence in overseas markets, which will allow for greater audience reach and maximize the commercial value of its diverse IP matrix [2].

泡泡玛特成立于2010年，是中国领先的潮流文化娱乐品牌。其核心业务围绕全球艺术家发掘、IP孵化运 营及全渠道消费者触达展开，构建了完整的 IP生态闭环。截至2023年年底，其业务已覆盖全球80余个 国家和地区，拥有超过450家线下门店及2300余台机器人商店。2024年，泡泡玛特海外乐园成功开设首 家门店，并实现国内省级行政区门店全覆盖（以西藏首家店为标志）。2025年4 月，LABUBU第三代搪 胶毛绒产品"前方高能"系列全球发售，短短几分钟内，美国、英国等地的库存被一扫而空。泡泡玛特的 成功，源于其对千禧一代情绪需求的深度洞察与精准回应，并通过 4P营销策略实现了崛起。 精准锁定千禧一代的情绪价值 在当代消费市场中，千禧一代逐渐成为主力消费群体。他们追求个性化、情感共鸣与精神满足，不再仅 仅为产品功能买单，而是更倾向于为情绪价值付费。泡泡玛特正是抓住了这一代消费者的心理诉求，成 功从一个潮流玩具品牌跃升为一家具有广泛影响力的文化 IP运营商。 1.不仅仅是卖玩具，更是讲好故事、打造人设 最近火爆的 LABUBU更是凭借其融合东方精怪与北欧神话的独特设计，以丑萌搞怪、亦正亦邪的风格 在潮玩市场中独树一帜。泡 ...

Core Insights - The Hong Kong stock market saw a net inflow of 100.18 billion HKD from northbound trading on October 22, with the Shanghai Stock Connect contributing 66.93 billion HKD and the Shenzhen Stock Connect contributing 33.25 billion HKD [1] Group 1: Stock Performance - The most bought stocks included the Tracker Fund of Hong Kong (02800), CNOOC (00883), and SMIC (00981) [1] - The most sold stocks were Hua Hong Semiconductor (01347), Xiaomi Group-W (01810), and Alibaba Group-W (09988) [1] - Alibaba Group-W had a buy amount of 19.67 billion HKD and a sell amount of 21.47 billion HKD, resulting in a net outflow of 1.80 billion HKD [2] - CNOOC (00883) received a net inflow of 14.24 billion HKD, supported by reports of long-term growth potential amid oil price fluctuations [5] - SMIC (00981) had a net inflow of 6.42 billion HKD, while Hua Hong Semiconductor (01347) faced a net outflow of 2.97 billion HKD [5] Group 2: Market Trends and Analyst Insights - Analysts suggest that the current external uncertainties, particularly the US-China tensions, are causing short-term market volatility, but a better entry point for investments may arise once these uncertainties diminish [4] - The semiconductor sector is experiencing a split, with a positive outlook on AI-driven growth, while domestic production capabilities are expected to accelerate due to US export controls [5] - Pop Mart (09992) reported a strong third-quarter performance with revenue growth of 245% to 250%, leading to an upward revision of earnings forecasts by Bank of America [5] - A strategic partnership between Innovent Biologics (01801) and Takeda Pharmaceutical is set to yield a total potential deal value of up to 114 billion USD, indicating significant growth prospects in the biotech sector [6][7]

今日（10月22日），港股市场全天表现低迷。 截至收盘，恒指报收于25781.77点，下跌245.78点，跌幅0.94%。 打开百度APP畅享高清图片 恒生科技指数报收于5923.09点，下跌84.85点，跌幅1.41%。 消息面，美银重申泡泡玛特"买入"评级，预计第四季将持续推出新产品。美银证券发表研究报告指出， 泡泡玛特第三季业绩表现强劲，收入按年增长245%至250%，超出市场预期。该行重申"买入"评级，目 标价为400港元。 此外，中银国际上调泡泡玛特目标价至405.6港元，维持"买入"评级。 瑞银上调泡泡玛特目标价至435港元；摩根大通上调泡泡玛特目标价至350港元；里昂维持泡泡玛特"跑 赢大市"评级。 焦点公司方面，中铝国际（601068.SH）A股涨停，带动H股午后飙升，最终收盘大涨30%。 消息面，有媒体称，力拓考虑与中铝集团进行资产换股权交易，但截至发稿，公司方面尚无正式消息发 布。 另外，泡泡玛特（09992.HK）公布财报后，今日高开近8%，但随后涨幅收窄，最终上涨2.4%，报256.4 港元。 其他方面，盘面上，科网股全线下跌，网易跌超3%，联想跌超2%，快手、百度、阿里巴巴、哔哩哔 ...

Group 1: Macroeconomic News - The price of 92-octane gasoline may return to the 6 yuan era, marking a four-year low, with a projected decrease of 320 yuan/ton, translating to a drop of 0.24 to 0.27 yuan per liter [2] - The current average price of 92-octane gasoline is 7.04 yuan/liter, expected to fall to a range of 6.77 to 6.80 yuan/liter after the adjustment [2] Group 2: Satellite and Space Technology - The first "Xiong'an-made" satellite, "Xiong'an No. 1," has completed production, marking a significant milestone in the intelligent manufacturing capabilities of the aerospace industry in Xiong'an New Area [2] - The satellite focuses on three key technological innovations: high-performance onboard computers, large flexible solar wings, and a new generation of Hall electric propulsion systems [2] Group 3: Pharmaceutical Industry - The first AI-assisted new drug MTS-004 has successfully completed Phase III clinical trials, becoming the first of its kind in China [3] - MTS-004 is designed for treating Pseudobulbar Affect (PBA) and addresses common swallowing difficulties with an orally disintegrating tablet formulation [3] Group 4: Technology and Innovation - Guangzhou has introduced a systematic action plan to accelerate the development of future industries, focusing on a dynamic development system that includes six core industries and multiple potential tracks [5] - The plan emphasizes continuous monitoring, technology sourcing, scenario-driven development, and collaborative governance to foster innovation [5] Group 5: Market Movements - The Hang Seng Technology Index fell by 2.12%, with major tech stocks experiencing declines, including NetEase down over 5% and Baidu and Alibaba down nearly 3% [5] - International spot gold prices saw a significant drop, with a one-day decline exceeding 6%, marking the largest drop in 12 years [5][6] Group 6: Corporate Developments - Cambrian Technology saw a surge of over 7%, with its market capitalization returning above 600 billion yuan, driven by positive sentiment in the computing chip sector [7] - Huawei announced the release of HarmonyOS 6, with over 23 million terminal devices now using HarmonyOS, highlighting significant user engagement and ecosystem development [8] - Yushun Technology received a patent for a robot joint control method based on motion capture technology, enhancing human-robot interaction capabilities [8] Group 7: Apple Inc. Developments - Apple's large foldable iPad project faces engineering challenges, potentially delaying its launch to 2029 or later due to issues with weight, functionality, and display technology [9]

| ** | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 代码 名称 | 现价 | | 淵跌 | 涨跌幅 | | | | | HSI | 恒生指数 | 25781.77c -245.78 | | -0.94% | | | | | HSTECH | 恒生科技 | 5923.09 c -84.85 | | -1.41% | | | | | HSBIO | 恒生生物科技 | 15732.53c -325.13 | | -2.02% | | | | | HSCEI | 恒生中国企业指数 | 9223.78c -78.88 | | -0.85% | | | | | HSCI | 恒生综合指数 | 3976.31c -37.98 | | -0.95% | | | | W | | | 老铺黄金(6181) | | | | | | | | 闭市 10-22 16:08:23 通 | | | | | | | 704.000 | | 额 21.72亿 股本 1.73亿 市盈 35.2 | | | | | 万得 | | -63.000 | ...

Core Insights - JPMorgan's report indicates that Pop Mart (09992) experienced a significant year-on-year sales growth of 245% in Q3, surpassing the bank's expectation of 140% and the market's expectation of 180% [1] - The quarter-on-quarter growth for Q3 is projected to be 64% [1] - For Q4, JPMorgan forecasts a year-on-year sales growth of 184%, driven by increased production capacity and upcoming traditional holidays such as Halloween, Thanksgiving, Black Friday, and Christmas [1] - The bank has raised its profit forecasts for Pop Mart for the years 2025 to 2027 by 9% to 17% [1] - The current projections for this year indicate a sales growth of 209% and a profit growth of 340% [1] - The target price for Pop Mart has been increased from HKD 320 to HKD 350, maintaining an "Overweight" rating [1]

智通财经APP获悉，摩根大通发布研报称，泡泡玛特(09992)第三季销售同比增长245%至250%，远超该 行预期的140%及市场预期的180%，按季比较第三季料增长64%。小摩预测泡泡玛特第四季销售同比增 长184%，当中主要受到产能增加及即将来临的万圣节、感恩节、黑色星期五及圣诞节等一系列传统节 日所推动，相应将其2025至2027年盈利预测上调9%至17%，目前预测今年销售及盈利同比分别增长 209%及340%，目标价从320港元上调至350港元，评级"增持"。 ...